LFB
France - ParisBiotechnology
Focus: LFB is a mid-cap European biotech specialist in plasma-derived therapeutics and recombinant coagulation factors, headquartered in Paris with 1,001–5,000 employees. The company focuses on rare hematologic and thrombotic diseases with a pipeline anchored in Phase 3 programs.
Profile data last refreshed 11h ago · AI intelligence enriched 1w ago
Employees
1001-5000
Open Jobs
88+126 this month
Hot — 167 jobs added in 30d
Net +126 (167 new, 41 removed). Aggressive expansion phase.
Should You Work at LFB?
AI assessmentLFB is a solid mid-cap rare-disease biotech with real near-term catalysts and strong operations hiring, but limited early-research upside; best for manufacturing, regulatory, and clinical operations professionals seeking scale-up execution.
Why Work Here
- Deep expertise in plasma fractionation and recombinant protein manufacturing—a niche with high barriers to entry and regulatory moats in rare disease hemostasis.
Data completeness
4/9 — Basic
Company HealthStrong
Pipeline
Mid-stage
2 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Blood samples for PK
Fibrinogen Deficiency in Complex Cardiac SurgeryClinical Trials (1)
NCT07425600Individualized Dose of Fibrinogen Following Cardiopulmonary Bypass
N/AHelp build intelligence for LFB
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.